KMT2A and acute leukemia: The characteristic changes in the KMT2A gene are associated with several oncogenic mechanisms, including the generation of oncogenic fusion proteins, epigenetic dysregulation, homeobox A (HOXA) cluster gene activation, and aberrant self‐renewal, contributing to the poor prognosis and therapeutic challenges that characterize KMT2A‐r acute leukemia.